Log in
Enquire now
RemeGen

RemeGen

RemeGen is a biopharmaceutical company with operations in China and the United States. The company develops and commercializes biological drugs for autoimmune, oncology, and ophthalmology diseases.

OverviewStructured DataIssuesContributors

Contents

remegen.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Drug development
Drug development
Engineering
Engineering
Technology
Technology
Biology
Biology
Location
China
China
Yantai
Yantai
Pitchbook URL
pitchbook.com/profiles...433088-92
Phone Number
+865353573511
Investors
Lilly Asia Ventures
Lilly Asia Ventures
Hudson Bay Capital
Hudson Bay Capital
0
OrbiMed
OrbiMed
Vivo Capital
Vivo Capital
Janchor Partners
Janchor Partners
Loyal Valley Capital
Loyal Valley Capital
Lake Bleu Capital
Lake Bleu Capital
Founded Date
2008
Total Funding Amount (USD)
100,000,000
Latest Funding Round Date
April 2, 2020
Country
China
China
Headquarters
Yantai
Yantai

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
100,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like RemeGen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.